Back
Inhibrx Vs. Keros Therapeutics Industry Stock Comparison
Buy
68
INBX
Inhibrx
Last Price:
34.23
Seasonality Move:
24.75%
Sell
11
KROS
Keros Therapeutics
Last Price:
50.41
Seasonality Move:
-8.67%
Buy
68
Inhibrx (INBX)
is a Buy
Is Inhibrx a Buy, Sell or Hold?
- The current Inhibrx [INBX] share price is $34.46. The Score for INBX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- INBX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
11
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $52.37. The Score for KROS is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $52.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 49.74 | Sell |
| Chaikin Money Flow: | -300465 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.1 - 34.52) | Buy |
| Bollinger Bands (100): | (34.15 - 37.31) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.95 | Sell |
| Relative Strength Index (14 RSI): | 36.65 | Sell |
| Chaikin Money Flow: | 62991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.12 - 58.96) | Sell |
| Bollinger Bands (100): | (51.5 - 65.24) | Sell |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.4 | Buy |
| 20-day SMA: | 34.28 | Buy |
| 50-day SMA: | 34.64 | Sell |
| 200-day SMA: | 27.94 | Buy |
| 8-day EMA: | 34.42 | Buy |
| 20-day EMA: | 34.41 | Buy |
| 50-day EMA: | 34.57 | Sell |
| 200-day EMA: | 30.47 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.99 | Sell |
| 20-day SMA: | 56.14 | Sell |
| 50-day SMA: | 60.52 | Sell |
| 200-day SMA: | 45.51 | Buy |
| 8-day EMA: | 54.04 | Sell |
| 20-day EMA: | 56.04 | Sell |
| 50-day EMA: | 57.96 | Sell |
| 200-day EMA: | 50.76 | Buy |
Inhibrx Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.08 per share, a decrease this year of $1.44 per share, and an increase next year of $0.91 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Inhibrx Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||